Clear cell sarcoma of the kidney in children: a clinopathologic analysis of three cases.

BACKGROUND Clear cell sarcoma of the kidney (CCSK) is a rare malignant tumor in children with uncertain histologic and immunohistologic traits. It mostly reveals atypical clinical symptoms similar to other familiar pediatric renal neoplasms, including abdominal mass, abdominal pain, hematuria, etc. Therefore, the lack of specificity in clinical symptoms may induce some challenging and controversial diagnoses. METHODS Three cases of CCSK were acquired data from the First Affiliated Hospital of Bengbu Medical College (China) in recent years, accompanied by clinical symptoms and imaging manifestations without obvious specificity, while abdominal mass and abdominal pain were described as the main manifestations; even the initial clinical diagnosis of one case was Wilms Tumor (WT). Two of them underwent a radical nephrectomy. All 3 cases were detected by hematoxylin-eosin (H&E) staining and immunohistochemistry. RESULTS Microscopic examination demonstrated the tumor component consisted of loose, locally dense tumor stroma and parenchyma composed of round or oval cells, which were separated by dendritic fibrosis. Afterwards, the unified immunophenotype were positive for Cyclin D1, Bcl-2, Vimentin, SATB-2, α-AACT, and Ki-67 (+, 30%, 40% and 80%, respectively). CONCLUSION Pathologic diagnosis of the disease should be comprehensively analyzed by multiple methods. More abundant morphologic, immunohistological, clinical and radiologic data can contribute to rigorous diagnosis and more accurate clinical treatment.

[1]  Edward Y Lee,et al.  Pediatric Renal Neoplasms:: MR Imaging-Based Practical Diagnostic Approach. , 2019, Magnetic resonance imaging clinics of North America.

[2]  C. Antonescu,et al.  BCOR Overexpression in Renal Malignant Solitary Fibrous Tumors: A Close Mimic of Clear Cell Sarcoma of Kidney , 2019, The American journal of surgical pathology.

[3]  Min Huang,et al.  Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors , 2018, Cell.

[4]  C. Antonescu,et al.  Diffuse Strong BCOR Immunoreactivity Is a Sensitive and Specific Marker for Clear Cell Sarcoma of the Kidney (CCSK) in Pediatric Renal Neoplasia. , 2018, The American journal of surgical pathology.

[5]  P. Tan,et al.  Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion , 2018, Histopathology.

[6]  Nicoleta C. Arva,et al.  Diagnostic Utility of Pax8, Pax2, and NGFR Immunohistochemical Expression in Pediatric Renal Tumors , 2017, Applied immunohistochemistry & molecular morphology : AIMM.

[7]  Vaishali A Walke,et al.  Renal Clear Cell Sarcoma - Anaplastic Variant: A Rare Entity. , 2017, Journal of clinical and diagnostic research : JCDR.

[8]  Narasimhan P. Agaram,et al.  BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities , 2016, The American journal of surgical pathology.

[9]  J. Karlsson,et al.  Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression , 2016, Oncotarget.

[10]  C. Bergeron,et al.  [Clear cell sarcoma of kidney in children]. , 2016, Bulletin du cancer.

[11]  A. Pession,et al.  Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney , 2015, OncoTarget.

[12]  C. Fletcher,et al.  Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney , 2015, Histopathology.

[13]  M. Fukuzawa,et al.  Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney , 2015, Nature Genetics.

[14]  P. Tan,et al.  Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney , 2015, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[15]  Amal Refaat,et al.  Clear cell sarcoma of the kidney: Patients' characteristics and improved outcome in developing countries , 2014, Pediatric blood & cancer.

[16]  K. Pritchard-Jones,et al.  Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study , 2014, British Journal of Cancer.

[17]  N Graf,et al.  Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. , 2013, European journal of cancer.

[18]  H. Ford,et al.  Large clear cell sarcoma of the kidney mistaken as Wilms' tumor , 2013 .

[19]  J. Dome,et al.  Clear cell sarcoma of the kidney: a review. , 2012, European journal of cancer.

[20]  J. Karlsson,et al.  Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney , 2012, The Journal of pathology.

[21]  B. Royer-Pokora Genetics of pediatric renal tumors , 2012, Pediatric Nephrology.

[22]  G. Hadley,et al.  Clear cell sarcoma of the kidney in children: experience in a developing country , 2010, Pediatric Surgery International.

[23]  N. Sebire,et al.  Paediatric renal tumours: recent developments, new entities and pathological features , 2009, Histopathology.

[24]  S. Sharma,et al.  Clear Cell Sarcoma of the Kidney , 2020, Definitions.

[25]  G. Vujanić,et al.  [Clear cell sarcoma of the kidney in children]. , 1992, Srpski arhiv za celokupno lekarstvo.

[26]  J. Seo,et al.  Clear cell sarcoma of the kidney--a case report. , 1989, Journal of Korean medical science.